Last reviewed · How we verify
NCT03733847
Rehabilitation Trajectories
trial in Musculoskeletal Disease in 524 participants. Completed in 31 December 2017.
31 December 2017
Quick facts
| Lead sponsor | National Resource Center for Rehabilitation in Rheumatology |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 524 |
| Start date | 1 November 2015 |
| Primary completion | 31 December 2017 |
| Estimated completion | 31 December 2017 |
Conditions studied
- Musculoskeletal Disease — all drugs for Musculoskeletal Disease →
Sponsor
National Resource Center for Rehabilitation in Rheumatology
Who can join
Adults 18 to 100, any sex, with Musculoskeletal Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of this multicentre cohort study is to provide evidence that can be used to improve continuity and quality in rehabilitation practice and rehabilitation processes across health care levels for patients with rheumatic and musculoskeletal diseases (RMDs).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03733847
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Musculoskeletal Disease
Currently open trials in the same condition.
- NCT06747052 — Gender Impact On Physical Activity In Chronic Musculoskeletal Disorders Prevention · recruiting
- NCT07261553 — Adherence to Home-Based Exercises in Musculoskeletal Disorders · recruiting
- NCT04037735 — RSA-RCT: Attune S+ TKA Versus Sigma TKA · NA · recruiting
Other National Resource Center for Rehabilitation in Rheumatology trials
Trials by the same sponsor.
- NCT03102788 — Task Shifting in the Care for Patients With Hand Osteoarthritis · NA · completed
- NCT03102814 — The BRIDGE Rehabilitation Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03733847 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Resource Center for Rehabilitation in Rheumatology
- Last refreshed: 28 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03733847.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing